News & Events

Jul 21, 2021

Press Releases

ViaCyte Appoints Dr. Jon Wilensky as Head of Surgery

Accomplished surgeon and researcher brings leadership to optimize subcutaneous delivery approaches as the company advances type 1 diabetes islet replacement therapies in the clinic SAN DIEGO, July 21, 2021 – ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it has appointed Jon Wilensky, MD, MBA, FACS, as Head of Surgery. […]

Read More

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.